Life Insurance with Ovarian Cancer 2026: Coverage, Rates & Best Carriers
An ovarian cancer diagnosis raises an obvious question: can I still buy life insurance, and if so, what will it cost? The answer in 2026 is more encouraging than most women expect. Ovarian cancer is not an automatic decline, and depending on the stage at diagnosis, the quality of your treatment records, and how long you have been in remission, traditional term and whole life coverage may well be within reach at standard — or near-standard — rates.
The path is different for everyone because underwriting for cancer history is genuinely case-by-case. Carriers weigh the type of cancer, the stage at diagnosis, the treatments you received, the time elapsed since treatment ended, your current follow-up status, and your age at diagnosis. This guide walks through each of those factors, shows realistic 2026 premium ranges, names the carriers that write ovarian cancer histories most competitively, and covers what to do if you have already been declined.
This short explainer covers what insurers look for after a cancer diagnosis:
Can You Get Life Insurance After Ovarian Cancer?
Yes — but the structure of your answer depends entirely on where you sit in your cancer journey. Underwriters divide applicants with any cancer history into two broad groups, and the distinction is the single most important factor in determining eligibility.
- Active ovarian cancer. You are currently in treatment (surgery, platinum-based chemotherapy, PARP inhibitors, immunotherapy) or have been diagnosed but have not completed a treatment course. Traditional fully underwritten life insurance is generally unavailable during active treatment.
- Ovarian cancer in remission. You have completed treatment and your oncologist considers you in remission or no evidence of disease (NED). The longer the clean interval, the more options open up — including term, whole life and simplified issue policies at competitive rates.
For women with active disease, guaranteed issue life insurance remains available regardless of health history. These policies require no medical exam and no health questions, but they carry a graded death benefit for the first two to three years and face amounts that are typically capped well below what a family actually needs.
How Ovarian Cancer Stage Affects Your Options
Stage at diagnosis is the strongest single predictor of how carriers will treat your application. Ovarian cancer is staged from I (confined to the ovaries) through IV (distant metastasis), and each step changes both the expected waiting period and the rate class you can realistically target.
| Stage at diagnosis | Typical waiting period | Realistic rate class | Notes |
|---|---|---|---|
| Stage I (localized) | 1–3 years post-treatment | Standard or near-standard | Best outcomes with clean CA-125 and imaging follow-ups |
| Stage II (pelvic extension) | 3–5 years post-treatment | Standard to Table 2–4 | Depends heavily on residual disease status |
| Stage III (peritoneal spread) | 5–10 years post-treatment | Table 2–6 or guaranteed issue | Some carriers decline; shop the impaired-risk market |
| Stage IV (distant metastasis) | Not typically considered | Guaranteed issue only | Traditional carriers generally will not offer coverage |
Two additional variables frequently move an application a full table rating in either direction: age at diagnosis (younger onset is scrutinized more closely) and whether the cancer carried a known hereditary marker such as BRCA1 or BRCA2. Documented genetic testing results, when negative, can actually help your case; when positive, they usually steer you toward carriers that specialize in impaired risk.
What Life Insurance Costs After Ovarian Cancer
Premiums for cancer survivors vary widely, but the table below gives a realistic 2026 anchor for a 50-year-old non-smoking woman buying $250,000 of 20-year term coverage. Table ratings each add approximately 25% to the standard premium, so a Table 2 rating means roughly 50% above standard and a Table 4 means roughly double.
| Health profile | Rate class | Est. monthly premium | Relative cost |
|---|---|---|---|
| No cancer history | Preferred Plus | $65 | Baseline |
| Ovarian cancer, Stage I, 5 years remission | Standard | $95–$110 | +45% to +70% |
| Ovarian cancer, Stage II, 5 years remission | Table 2–4 | $145–$200 | +120% to +200% |
| Ovarian cancer, Stage III, 7+ years remission | Table 4–6 | $200–$290 | +200% to +350% |
| Active disease / recent diagnosis | Guaranteed issue ($25,000) | $150+ | N/A — small face amount |
Note that a flat extra charge sometimes replaces a table rating. Underwriters may approve an application at standard rates with a flat extra of, say, $8.50 per thousand for a fixed number of years. On a $100,000 policy that adds about $850 annually for the stated period, after which the surcharge drops off and the premium returns to the standard rate for the remainder of the term.
Best Carriers for Ovarian Cancer Survivors in 2026
Carrier selection is where the real money is saved. The same applicant can receive a Standard offer from one insurer and a Table 4 from another, and over a 20-year term that gap can exceed $40,000. The carriers below are consistently the most competitive for cancer histories.
| Carrier | Best for | Typical minimum remission | Products |
|---|---|---|---|
| Mutual of Omaha | Early-stage gynecologic cancers, simplified issue | 2+ years | Term, whole, universal, simplified issue |
| Banner Life | Lowest term rates for standard-qualifying survivors | 3+ years | Term, universal — individual case review |
| Lincoln Financial | Early-stage cancers with strong records | 3+ years | Term, universal, indexed universal |
| Prudential | Well-documented long-term remission | 5+ years | Term, universal, variable universal |
| Pacific Life | Preferred-risk survivors with clean follow-up | 5+ years | Term, universal, indexed universal |
| Gerber Life | Guaranteed issue fallback, ages 50–80 | None | Guaranteed issue whole life up to $25,000 |
The practical takeaway: start with the carriers known for individual case review rather than automated decision engines, and have your oncology records organized before you apply. Underwriting for a cancer history typically takes eight to twelve weeks — two to three times a standard application — so responding quickly to records requests directly shortens your timeline.
Compare Free Life Insurance Quotes
Answer a few questions and see personalized rates from 50+ carriers in about two minutes. No obligation.
Secure form — your information is encrypted and never sold.
What to Have Ready Before You Apply
- Complete pathology and surgical reports, including the exact stage and grade at diagnosis.
- Dates and types of every treatment — surgery, chemotherapy regimens, maintenance therapy, radiation.
- Your most recent CA-125 results, imaging reports and oncology follow-up notes.
- Any genetic testing results, including BRCA and other hereditary cancer panel findings.
- A written statement from your oncologist describing your current status and prognosis.
- A list of all medications and any current symptoms or late treatment effects.
If You Have Been Declined
A decline from one carrier is not the end of the road. It usually means the case went to a company with rigid guidelines rather than one that reviews cancer histories individually. Two paths remain open.
- Simplified issue life insurance — a short yes/no health questionnaire, no medical exam, coverage typically $5,000 to $50,000, full benefit from day one. Critically, carriers ask different questions, so the wording of the cancer or hospitalization question can decide approval.
- Guaranteed issue final expense — no health questions at all. Expect a two-year graded death benefit, meaning a non-accidental death in the first two years returns premiums plus interest rather than the full face amount.
If you have been declined, do not simply accept the decision. An independent broker can reshop the file to carriers with more flexible gynecologic cancer guidelines, often producing an approval where the first carrier said no.
Common Mistakes to Avoid
- Applying to a single carrier instead of shopping at least five, given how widely cancer guidelines differ.
- Waiting to apply until every follow-up is complete when a simplified issue policy could be issued today.
- Leaving out treatment details — incomplete disclosures are the leading cause of claim disputes.
- Assuming a family history of ovarian or breast cancer means automatic decline; it usually produces only a mild rating.
- Buying coverage far below your actual need because a Table rating raised the price — a smaller face amount at a rated premium may still leave your family short.
Frequently Asked Questions
Can I get life insurance with ovarian cancer in remission?
Yes. Survivors of early-stage ovarian cancer who have completed treatment and been in remission for one to three years can often qualify for traditional term or whole life coverage at standard or near-standard rates. Later-stage histories typically require longer waiting periods and may be table-rated.
How long do I need to wait after treatment?
Stage I histories are commonly considered after one to three years; Stage II after three to five; Stage III after five to ten. Individual carriers set their own guidelines, and some will review a case earlier if the prognosis is favorable and follow-up records are strong.
Does a BRCA mutation affect life insurance?
A known BRCA1 or BRCA2 mutation is treated as a risk factor but rarely causes a decline on its own. Negative genetic testing can support your application. Positive results steer the case toward carriers that specialize in impaired risk and review hereditary cancer histories individually.
Can I get coverage while I am still in treatment?
Traditional fully underwritten coverage is generally unavailable during active treatment. Guaranteed issue whole life has no health questions and remains available, with coverage typically capped at $25,000 and a two-year graded benefit period.
Will ovarian cancer history affect an employer group policy?
Group life through an employer is usually issued on a guaranteed-acceptance basis during initial enrollment, so a prior diagnosis generally does not affect that coverage. However, group coverage ends with employment and should be supplemented with an individually owned policy.
How much more will I pay than someone without a cancer history?
Early-stage survivors commonly pay 45% to 70% above a Preferred Plus rate. Later-stage histories may see 120% to 350% above standard, or a flat extra charge for a fixed number of years followed by a return to standard pricing.
Related Resources
- National Cancer Institute — Ovarian Cancer
- AM Best — Insurance Company Financial Strength Ratings
- NAIC — Consumer Insurance Resources and Policyholder Rights
Related Reading
For more on how cancer histories are underwritten, see our guides to life insurance with a cancer history, life insurance for cancer survivors, life insurance with breast cancer, life insurance after a cancer diagnosis, and guaranteed issue life insurance.
Get Your Free Life Insurance Quote
An ovarian cancer history does not have to mean uninsurable. With the right carrier, the right documentation and the right product, coverage is achievable — and often far more affordable than a first declined application suggests. Compare free quotes from dozens of top-rated carriers and see what you qualify for today. Read our buying guide or request your personalized quotes now.
